Effect of renal function on the pharmacokinetics of LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor

被引：0
|
作者：
Surya P. Ayalasomayajula
Thomas H. Langenickel
Pierre Jordaan
Wei Zhou
Priyamvada Chandra
Diego Albrecht
Parasar Pal
Iris Rajman
Gangadhar Sunkara
机构：
[1] Novartis Institutes for BioMedical Research,Drug Metabolism and Pharmacokinetics
[2] Novartis Pharma AG,Translational Medicine, Clinical Pharmacology and Profiling
[3] Novartis Healthcare Pvt Ltd,undefined
来源：
European Journal of Clinical Pharmacology | 2016年 / 72卷
关键词：
Angiotensin receptor neprilysin inhibitor; LCZ696; Pharmacokinetics; Renal impairment; Valsartan; Sacubitril;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1065 / 1073
页数：8
相关论文
共 50 条
  • [31] Cardioprotective effect of LCZ696 (sacubitril/valsartan) experimental acute myocardial infarction
    Ishii, M.
    Kaikita, K.
    Sato, K.
    Sueta, D.
    Fujisue, K.
    Oimatsu, Y.
    Mitsuse, T.
    Hokimoto, S.
    Ogawa, H.
    Tsujita, K.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1412 - 1412
  • [32] Treatment with LCZ696, an Orally Active Angiotensin Receptor Neprilysin Inhibitor Prevents Ischemic Brain Damage
    Bai, Hui-Yu
    Mogi, Masaki
    Nakaoka, Hirotomo
    Kan-no, Harumi
    Tsukuda, Kana
    Chisaka, Toshiyuki
    Wang, Xiao-Li
    Kukida, Masayoshi
    Shan, Bao-Shuai
    Iwanami, Jun
    Horiuchi, Masatsugu
    HYPERTENSION, 2014, 64
  • [33] Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients
    Desai, Akshay S.
    McMurray, John J. V.
    Packer, Milton
    Swedberg, Karl
    Rouleau, Jean L.
    Chen, Fabian
    Gong, Jianjian
    Rizkala, Adel R.
    Brahimi, Abdel
    Claggett, Brian
    Finn, Peter V.
    Hartley, Loren Howard
    Liu, Jiankang
    Lefkowitz, Martin
    Shi, Victor
    Zile, Michael R.
    Solomon, Scott D.
    EUROPEAN HEART JOURNAL, 2015, 36 (30) : 1990 - 1997
  • [34] Safety and efficacy of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Japanese patients with hypertension and renal dysfunction
    Sadayoshi Ito
    Minoru Satoh
    Yuko Tamaki
    Hiromi Gotou
    Alan Charney
    Naoko Okino
    Mizuki Akahori
    Jack Zhang
    Hypertension Research, 2015, 38 : 269 - 275
  • [35] Effect of the angiotensin receptor neprilysin inhibitor LCZ696 compared with enalapril according to baseline risk in PARADIGM-HF
    Simpson, J.
    Squire, I. B.
    Martinez, F.
    Rouleau, J. L.
    Swedberg, K.
    Zile, M.
    Lefkowitz, M.
    Packer, M.
    Mcmurray, J. J. V.
    Solomon, S. D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 295 - 296
  • [36] LCZ696 (Sacubitril/Valsartan) Can We Predict Who Will Benefit?
    Dec, G. William
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (19) : 2072 - 2074
  • [37] Safety and efficacy of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Japanese patients with hypertension and renal dysfunction
    Ito, Sadayoshi
    Satoh, Minoru
    Tamaki, Yuko
    Gotou, Hiromi
    Charney, Alan
    Okino, Naoko
    Akahori, Mizuki
    Zhang, Jack
    HYPERTENSION RESEARCH, 2015, 38 (04) : 269 - 275
  • [38] Efficacy and Safety of LCZ696, a First-in-Class Angiotensin Receptor Neprilysin Inhibitor, in Asian Patients With Hypertension
    Kario, Kazuomi
    Sun, Ningling
    Chiang, Fu-Tien
    Supasyndh, Ouppatham
    Baek, Sang Hong
    Inubushi-Molessa, Akiko
    Zhang, Ying
    Gotou, Hiromi
    Lefkowitz, Martin
    Zhang, Jack
    HYPERTENSION, 2014, 63 (04) : 698 - 705
  • [39] Effect of the angiotensin receptor-neprilysin inhibitor sacubitril/valsartan on the pharmacokinetics and pharmacodynamics of a single dose of furosemide
    Ayalasomayajula, Surya
    Schuehly, Uwe
    Pal, Parasar
    Chen, Fabian
    Zhou, Wei
    Sunkara, Gangadhar
    Langenickel, Thomas H.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 84 (05) : 926 - 936
  • [40] PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES OF LCZ696, A NOVEL DUAL-ACTING ANGIOTENSIN RECEPTOR NEPRILYSIN INHIBITOR (ARNI)
    Gu, J.
    Noe, A.
    Chandra, R.
    Al-Fayoumi, S.
    Ligueros, M.
    Sarangapani, R.
    Maahs, S.
    Ksander, G.
    Rigel, D.
    Jeng, A.
    Dole, W.
    JOURNAL OF HYPERTENSION, 2009, 27 : S9 - S9
12345